AF
MGNX icon

Amalgamated Financial’s MacroGenics MGNX Stock Holding History

Amalgamated Financial’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$84K Buy
+9,573
New +$106K ﹤0.01% 2216

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Amalgamated Financial's MGNX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in MacroGenics (MGNX) in Q1 2022: 9,573 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #2216 among its holdings.

144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Amalgamated Financial held 9,573 shares of MacroGenics worth $84K as of Q1 2022.
  • MacroGenics was a new Amalgamated Financial position in Q1 2022.
  • MacroGenics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2216 holding.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.